LinkedIn image ad examples
4,744 image ads are live on LinkedIn right now, from 1,895 companies. Browse real ones, filtered by industry.
- Calea UKRecorded 8 Oct 2026
Learn more about Calea’s services and how our 24/7 Advice Line supports patients on Home Parenteral Support, helping them live confidently at home: https://calea.co.uk/ This post is for healthcare professionals only.
- GoodpathSince 2 Oct 2026
GLP-1s are one of the fastest-growing costs in your benefits plan, and most employers are overpaying. Goodpath's carve-out puts you back in control.
- Clinical.lyRecorded 8 Oct 2026
Financial management shouldn’t depend on someone remembering where the information lives. When budgets, billables, invoices, and payments are tracked across spreadsheets and disconnected processes, it becomes harder to see what’s been captured and what may have been missed. The Financial Health Check helps research sites take a closer look at the processes behind their financial operations and identify where greater consistency and visibility could make a difference. Download the free workbook → https://lnkd.in/gnVwDAnu/?utm_campaign=SiteFinancialCheckWorkbook&utm_source=linkedin&utm_medium=paid&utm_id=1207481056&hsa_acc=514323643&hsa_cam=1207481056&hsa_grp=904304406&hsa_ad=1623272076&hsa_net=linkedin&hsa_ver=3
- Clinical.lyRecorded 8 Oct 2026
Your site can be busy, enrolling, and growing, and still be leaving revenue behind. A missed billable here. A reconciliation delay there. Small financial gaps can add up, even when everything seems to be running smoothly. The Financial Health Check is a free 10-minute workbook designed to help research sites assess seven areas of financial health and identify where revenue may be slipping through the cracks. Take the Financial Health Check → https://lnkd.in/gnVwDAnu/?utm_campaign=SiteFinancialCheckWorkbook&utm_source=linkedin&utm_medium=paid&utm_id=1207481056&hsa_acc=514323643&hsa_cam=1207481056&hsa_grp=904304406&hsa_ad=1623351486&hsa_net=linkedin&hsa_ver=3
- Care to TranslateSince 19 Sept 2026
Der EU AI Act verändert, wie Gesundheitseinrichtungen KI einsetzen dürfen – auch für Übersetzungen. Was bedeutet das für Ihre Klinik oder Organisation? Erfahren Sie, welche Anforderungen bei Transparenz, KI-Kompetenz, Datenschutz und menschlicher Kontrolle gelten und worauf Sie bei KI-Übersetzungen im Gesundheitswesen achten sollten.
- Johnson & JohnsonSince 5 Oct 2026
Help accelerate the journey from breakthrough to benefit for patients. Join us and be parts of what's next.
- Johnson & JohnsonSince 5 Oct 2026
Advance therapies, champion patients, and help shape the future of healthcare. Be a part of what’s next.
- Berry Consultants, LLCSince 21 Sept 2026
This week on “In the Interim…”, Dr. Scott Berry talks with Dr. Alun Bedding, a statistician turned professional certified coach, and former global head of statistical methods at Roche, about what coaching is, and why it looks a lot like good trial design consulting. A few highlights from the conversation: ✅️ Why coaching starts by determining the goal, not accepting the first request ✅️ Why real progress requires discomfort, not reassurance ✅️ Why blind spots make self-coaching unreliable ✅️ Where AI coaching helps, and where it can't replace human judgment Tune into the full episode today which will not require discomfort: https://lnkd.in/gTYaZpeh
- EvinovaSince 22 Sept 2026
Programs using Evinova's Cost module have delivered $350M in savings over three years, with ~$200M in opportunities identified within four weeks. Evinova's Cost module brings instant cost transparency into study design, so teams can: - Benchmark against your company's and industry history - Reveal cost drivers by visit, patient, country and site - Compare outsourced, insourced and hybrid models - Optimize total cost while preserving scientific intent Download the full overview or learn more at evinova.com
- EverlabRecorded 8 Oct 2026
This partnership has been more than 12 months in the making. From this week, Accenture is bringing Everlab to its people across Australia and New Zealand. Fully funded programs for managers and above, with corporate rates the business has secured for its wider workforce. The business case for testing a leadership team has always been straightforward to make. Going wider was where the honest answer was usually "not this year", because running it properly across a whole workforce wasn't something anyone could realistically deliver. That's what's changed. We're now doing this at a scale that wasn't feasible a few years ago, across 1,800+ provider locations and two countries, with the sequencing and continuity of care that makes it work. Matt Coates, Accenture's ANZ Digital Core Lead, went through the program himself before any of this went live and had this to say: "It's been great to get a clearer picture of my health, with the Everlab doctor helping turn the data into actions I could actually take. It feels very personalised and practical, and the app is great for tracking progress." "Actions I could actually take" is the line I'd point to. Testing on its own changes nothing. What changes something is a doctor who forms a complete picture of your health, tells you the two or three things that matter for you specifically, and builds a plan around what's realistic. Credit to the Accenture team for the ambition here. Funding programs for managers and above while opening access to everyone else at the same time is a serious undertaking on their side as much as ours. Looking forward to the health outcomes we can help their team reach in the years to come.
- BenchSciRecorded 8 Oct 2026
Reuters confirms Anthropic has a wet lab — and Anthropic won't say what it's for. I wonder why... "Anthropic has set up a wet lab in the San Francisco Bay Area, a place to run physical biology experiments rather than simulate them. The company confirms it exists, yet it will not say what it is for, beyond ruling out the obvious answer, which is drug discovery." "Life sciences is now among Anthropic’s largest areas by headcount and spending, and it has been recruiting a procurement lead and a biochemical specialist." “We absolutely are doing that today, and I would describe our approach as being typical of what you would see in most biotech companies" "Reuters has linked part of the campaign to Dario Amodei personally since the disease killed his father before a cure was found." https://lnkd.in/gMk8vTQn https://lnkd.in/gvcdBrbe
- DiscngineSince 28 Sept 2026
How much of the promise of Large Language Models (LLMs) has reached drug discovery in practice? LLMs have gained strong momentum across pharma, with dedicated teams developing and experimenting with these technologies. Their effect on discovery workflows, however, is still taking shape, and many of the benefits initially expected remain to be demonstrated in practice. Discngine Meetup Vol. 6 - our annual two-hour virtual event - explores this topic with experts from pharma and academia sharing hands-on experience and insights. Designed for drug discovery scientists and computational experts, the programme will cover: • How LLMs and multi-agent systems are currently used across the DMTA cycle • Where they provide value today and where limitations remain • What comes next for agentic AI in discovery workflows Andreas Bender (Khalifa University) will open the event with a characterization of LLM agents in drug discovery, followed by talks from Christopher McClendon (Pfizer) and Samuel Genheden (AstraZeneca). 📅 Tuesday, October 20th | 🕒 4:00 PM (CET) / 10:00 AM (EDT) | 📍 Online | 🆓 Free event Explore the full agenda and register today 👇 #discngine #onlineevent #LargeLanguageModels #LLM #AIindrugdiscovery #drugdiscovery #computationalchemistry
- DiscngineSince 28 Sept 2026
How much of the promise of Large Language Models (LLMs) has reached drug discovery in practice? Discngine Meetup Vol. 6 - our annual two-hour virtual event - brings experts from pharma and academia together to share hands-on experience with LLMs and multi-agent systems. Designed for drug discovery scientists and computational experts, the programme will cover: • How LLMs are currently used across the DMTA cycle • Where they provide value today and where limitations remain • What comes next for agentic AI in discovery workflows 📅 October 20th, 2026 | 🕒 4:00 PM (CET) / 10:00 AM (EDT) | 📍 Online | 🆓 Free event Explore the full agenda and register today 👇 #discngine #onlineevent #LargeLanguageModels #LLM #AIindrugdiscovery #drugdiscovery #computationalchemistry
- Exelint InternationalSince 22 Sept 2026
Designed to reach where standard syringes can’t. Curved Tip Syringes offer added control and precision when flushing, irrigating, or delivering liquids to hard-to-reach areas. 🦷 In dental care, their curved design can support applications such as: • Irrigation following dental procedures • Flushing debris from difficult-to-reach areas • Periodontal irrigation and cleaning • Controlled delivery of appropriate solutions Learn more about Exel International’s dental product solutions and how we support healthcare professionals worldwide: https://lnkd.in/gF9ZBUn5 #ExelMedicalProducts #DentalCare #DentalProducts #DentalSupplies #DentalProfessionals #MedicalDevices #ExelInternational
- ClarvidaRecorded 8 Oct 2026
Put your experience to work where it can make a difference. 💙 Clarvida is hiring BCBA's in Virginia to support individuals and families through quality behavioral health services. Explore this career opportunity and apply today.
- ClarvidaRecorded 8 Oct 2026
Your skills can help create positive change for the people and communities we serve. 💙 Clarvida is hiring RBT professionals in Virginia who are ready to bring their expertise and compassion to meaningful work. Learn more about the position and apply today.
- IOT LensesSince 22 Sept 2026
Join us at SILMO Paris 2026! 👓✨ We're bringing something exciting to Paris next week. Visit us in Hall 6, Booth K175 to discover our latest innovations in lens design and technology, and learn more about Neochromes One, our premium photochromic lens engineered to deliver exceptional responsiveness to changing light conditions. 👉Schedule a meeting with our team and be among the first to see what's next. Link in comments. #SILMOParis #NeochromesOne #IOTLenses #seethedifference
- Eurofins DiscoverXSince 22 Sept 2026
FIRST Collaborative GPCR #Podcast! The GPCR resurgence is here & physiological relevance is at the center of it. The new podcast from Eurofins DiscoverX & Dr. GPCR features Jane Lamerdin, Gaurav Agrawal, Ph.D., & Yamina Berchiche discussing why target expression, cellular context, & receptor biology are critical for generating data that translates to the clinic. From obesity therapeutics & GLP-1 biology to the complexities of amylin receptors, discover what's driving renewed excitement in #GPCRdrugdiscovery. 🎙️ Now live! Listen in & learn what's shaping the next wave of GPCR innovation including personal GPCR-related experiences from the speakers. https://lnkd.in/gpr6qqY8 #GPCR #DrugDiscovery #ObesityResearch #AssayDevelopment #Biotech #GPCRPodcast
- InductiveSince 23 Sept 2026
To celebrate our third consecutive 1st place win out of 750+ total competitors, we're opening free access to our ADMET AI models for a limited number of small-molecule discovery teams. Full Compass access and support included. Apply below to try it on your own program.
- Claimable, Inc.Recorded 8 Oct 2026
A denied insurance claim is only a billing problem if you can afford to pay out of pocket. About a third of Americans struggle to cover an unexpected $400 expense, so for a lot of people, a denied claim is the difference between getting care and going without it. Wall Street veteran and founder of Your Rich BFF Media, Vivian Tu, invited me on her podcast, Networth and Chill, to break down the money side of claim denials: Why denials happen (hint: it's not usually a mistake) Which claims get denied the most, and why What to actually do in the first 30 days after a denial Why appealing wins more often than people think Most people don't know they have the right to fight back, so thank you, Vivian, for bringing this info to your listeners. You can listen to the full podcast here: https://lnkd.in/g3Fjgyet
- Claimable, Inc.Recorded 8 Oct 2026
Thanks to John Tozzi for making the trek to the tech capital of the world, Des Moines, Iowa 😂 - what Bloomberg Businessweek called "an unlikely launchpad for a startup taking on America's biggest insurers." We'll take it. John captured the heart of what we're building at Claimable, Inc. from all angles. The relentless patient advocacy that Warris Bokhari, MD leads, spanning nights and weekends, is literal lifesaving work. That work directly informs how we build and scale our commercial product, so we can help orders of magnitude more patients through our partnerships with pharma manufacturers, specialty pharmacies, health systems and many others. Huge shoutout to our investors who back this mission: Josh, David, Liz, and a crew that includes Mark Cuban, whose relentless pursuit to "f--- up healthcare" is something we're proud to be a part of. https://lnkd.in/gzswxS2K
- EnergiqueRecorded 8 Oct 2026
Looking for a more practical approach to homeopathic drainage support? Start with the Quick Start Guide to Detox, created to give practitioners like you useful information you can put into practice immediately. You’ll also receive information about Lymphdrainex® and a special product offer for new Energique practitioners. Download the Guide + Get the Product Offer
- EnergiqueRecorded 8 Oct 2026
Need better resources for supporting homeopathic drainage and detox in your practice? Start here. Get the Quick Start Guide to Detox, plus information on Lymphdrainex®, one of Energique’s practitioner formulas for homeopathic drainage and detoxification support. New to Energique? There’s an added product offer waiting for you, too. Get the Detox Guide & Product Offer
- BranchLabRecorded 8 Oct 2026
This week, we're spotlighting one of the most critical states in healthcare advertising. New York may not have a single comprehensive privacy law, but that does not make one of the country’s most populous states simple for healthcare advertisers. Online tracking is the pressure point right now. Regulators are scrutinizing whether opt-outs actually stop tracking, courts have allowed cases against healthcare websites to move forward, and NYHIPA still looms large, with the potential to bring much stricter rules for health-related advertising. Read the brief and explore the full map to track state-by-state analysis of key privacy legislation, enforcement activity, case law, and the potential implications for healthcare advertising and commercialization. https://lnkd.in/gevafEtq
Other LinkedIn formats
Watch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.